APA (7th ed.) Citation

Wu, P., Lin, H., Chen, H., Huang, P., & Ke, M. Metabolic Outcomes of Changing From Rilpivirine/Tenofovir Disoproxil Fumarate/Emtricitabine to Rilpivirine/Tenofovir Alafenamide/Emtricitabine: A Longitudinal Study. Wiley.

Chicago Style (17th ed.) Citation

Wu, Ping‐Feng, Hsi‐Hsun Lin, Hsin‐Pai Chen, Po‐Chieh Huang, and Meng‐Yu Ke. Metabolic Outcomes of Changing From Rilpivirine/Tenofovir Disoproxil Fumarate/Emtricitabine to Rilpivirine/Tenofovir Alafenamide/Emtricitabine: A Longitudinal Study. Wiley.

MLA (9th ed.) Citation

Wu, Ping‐Feng, et al. Metabolic Outcomes of Changing From Rilpivirine/Tenofovir Disoproxil Fumarate/Emtricitabine to Rilpivirine/Tenofovir Alafenamide/Emtricitabine: A Longitudinal Study. Wiley.